Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 14.135.497.707.20-2.11

What is the latest EBIT Margin ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Margin ratio of SOTAC PHARMACEUTICALS is 14.13 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.13
Mar20245.49
Mar20237.70
Mar20227.20
Mar2021-2.11

How is EBIT Margin of SOTAC PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 14.13
157.38
Mar2024 5.49
-28.70
Mar2023 7.7
6.94
Mar2022 7.2
Positive
Mar2021 -2.11 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹100.0 Cr -0.4% -15.1% -21% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-0.4%

-15.1%

-21%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses